Minutes of the EGM for the 9 of November, 2023

Minutes of the Extraordinary General Meeting (the “Meeting”) of IGEA Pharma N.V., a public limited company (in Dutch: naamloze vennootschap), having its statutory seat in Amsterdam, the Netherlands, and its registered office address at Siriusdreef 17, 2132WT Hoofddorp, the Netherlands, registered with the Trade Register of the Dutch Chamber of Commerce under number: 70212821 (the “Company”), held physically at Gustav Mahlerlaan 308, 1082ME Amsterdam, the Netherlands on 11 November 2023 at 14:05 hours CET.

Read More

IGEA to update on RBCARE business combination

Microsoft Word – 20231009 igea_press release

FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN

Read More

IGEA and RBCARE2023 signed to combine their businesses

FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT
FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION
IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES,
AUSTRALIA, CANADA, OR JAPAN

Read More

Convening notice

Dear Shareholder,
The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby
invites you to attend the Annual General Meeting on 09.11.2023 (the “AGM”) that will take
place at Tribes Amsterdam South Axis FOZ, Gustav Mahlerlaan 308, 1082 ME Amsterdam,
the Netherlands. The meeting will start at 14:00 hours CEST and is to be attended physically.
Registration will start at 13:00 hours CEST.

Read More

IGEA to update on SIX decision

Hoofddorp, the Netherlands, 4 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the intention to appeal the decision of the SIX to delist the company.

Read More